Eli Lilly said Wednesday its combination antibody therapy "significantly" reduced COVID-19 deaths and hospitalizations in a phase 3 study.
In a study consisting of more than 750 high-risk patients with COVID-19, the company said a combination of bamlanivimab and etesevimab cut the risk of hospitalization and death by 87 percent, Reuters reports.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
The hunt for Planet NineUnder The Radar Researchers seeking the elusive Earth-like planet beyond Neptune are narrowing down their search
-
Magazine interactive crossword - April 26, 2024Puzzles and Quizzes Issue - April 26, 2024
-
Magazine solutions - April 26, 2024Puzzles and Quizzes Issue - April 26, 2024
-
Texas dairy worker gets bird flu from infected cowSpeed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
-
Dengue hits the Americas hard and earlySpeed Read Puerto Rico has declared an epidemic as dengue cases surge
-
US bans final type of asbestosSpeed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical recordsSpeed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
-
Afghanistan has a growing female suicide problemSpeed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
-
US life expectancy rose in 2022 but not to pre-pandemic levelsSpeed Read Life expectancy is slowly crawling back up
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid scienceSpeed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
-
An increasing number of dog owners are 'vaccine hesitant' about rabiesSpeed Read A new survey points to canine vaccine hesitancy
